Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
-
Published:2024-04
Issue:4
Volume:13
Page:936-939
-
ISSN:2218-6751
-
Container-title:Translational Lung Cancer Research
-
language:
-
Short-container-title:Transl Lung Cancer Res
Publisher
AME Publishing Company